Reply
Arpan Jain, Barjesh Chander Sharma – 23 December 2021
Arpan Jain, Barjesh Chander Sharma – 23 December 2021
Vincent L. Chen, Nathan S. Ramrakhiani, Mindie H. Nguyen – 23 December 2021
Lorenzo Ridola, Silvia Nardelli, Stefania Gioia, Jessica Faccioli, Oliviero Riggio – 23 December 2021
Prashanth Francis, Lisa M. Forman – 22 December 2021
Anatoliy I. Masyuk, Tatyana V. Masyuk, Christy E. Trussoni, Nicholas E. Pirius, Nicholas F. LaRusso – 22 December 2021
Yuan Lin, Meng‐Qi Dong, Zhi‐Min Liu, Meng Xu, Zhi‐Hao Huang, Hong‐Juan Liu, Yi Gao, Wei‐Jie Zhou – 22 December 2021
Indu G. Rajapaksha, Lakmie S. Gunarathne, Khashayar Asadi, Ross Laybutt, Sof Andrikopoulous, Ian E. Alexander, Mathew J. Watt, Peter W. Angus, Chandana B. Herath – 22 December 2021 – Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease and is frequently associated with type 2 diabetes. However, there is no specific medical therapy to treat this condition. Angiotensin‐converting enzyme 2 (ACE2) of the protective renin angiotensin system generates the antifibrotic peptide angiotensin‐(1‐7) from profibrotic angiotensin II peptide.
Tran Nguyen, Trang Pham, Loc Phan, Gary Mize, Amy Trang, Diem Dao, Anh Le, Robert Gish, William M. Lee, Dung Do, Hong K. Tang, Hai T. Phan, Binh T. Nguyen, Doan Y Dao – 22 December 2021
Camille A. Kezer, Vijay H. Shah, Douglas A. Simonetto – 22 December 2021
Xinrong Zhang, Grace Lai‐Hung Wong, Terry Cheuk‐Fung Yip, Yee‐Kit Tse, Lilian Yan Liang, Vicki Wing‐Ki Hui, Huapeng Lin, Guan‐Lin Li, Jimmy Che‐To Lai, Henry Lik‐Yuen Chan, Vincent Wai‐Sun Wong – 21 December 2021